| Immune evasion in pancreatic cancer: from mechanisms to therapy N Martinez-Bosch, J Vinaixa, P Navarro Cancers 10 (1), 6, 2018 | 206 | 2018 |
| Key contribution of CPEB4-mediated translational control to cancer progression E Ortiz-Zapater, D Pineda, N Martínez-Bosch, G Fernández-Miranda, ... Nature medicine 18 (1), 83-90, 2012 | 170 | 2012 |
| Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk CA Orozco, N Martinez-Bosch, PE Guerrero, J Vinaixa, T Dalotto-Moreno, ... Proceedings of the National Academy of Sciences 115 (16), E3769-E3778, 2018 | 156 | 2018 |
| Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer O Roda, E Ortiz–Zapater, N Martínez–Bosch, R Gutiérrez–Gallego, ... Gastroenterology 136 (4), 1379-1390. e5, 2009 | 118 | 2009 |
| Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation N Martínez-Bosch, MG Fernández-Barrena, M Moreno, E Ortiz-Zapater, ... Cancer research 74 (13), 3512-3524, 2014 | 113 | 2014 |
| A novel translational control mechanism involving RNA structures within coding sequences J Jungfleisch, DD Nedialkova, I Dotu, KE Sloan, N Martinez-Bosch, ... Genome research 27 (1), 95-106, 2017 | 59 | 2017 |
| Impact of galectins in resistance to anticancer therapies P Navarro, N Martínez-Bosch, AG Blidner, GA Rabinovich Clinical Cancer Research 26 (23), 6086-6101, 2020 | 47 | 2020 |
| Knockdown of α2, 3-sialyltransferases impairs pancreatic cancer cell migration, invasion and e-selectin-dependent adhesion PE Guerrero, L Miró, BS Wong, A Massaguer, N Martínez-Bosch, ... International journal of molecular sciences 21 (17), 6239, 2020 | 33 | 2020 |
| Increased plasma levels of galectin-1 in pancreatic cancer: Potential use as biomarker N Martinez-Bosch, LE Barranco, CA Orozco, M Moreno, L Visa, M Iglesias, ... Oncotarget 9 (68), 32984, 2018 | 33 | 2018 |
| Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis N Martínez-Bosch, H Cristóbal, M Iglesias, M Gironella, L Barranco, L Visa, ... EBioMedicine 75, 2022 | 27 | 2022 |
| Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities N Martinez-Bosch, A Rodriguez-Vida, N Juanpere, J Lloreta, A Rovira, ... Nature Reviews Urology 16 (7), 433-445, 2019 | 27 | 2019 |
| The galectin family as molecular targets: hopes for defeating pancreatic cancer N Manero-Rupérez, N Martínez-Bosch, LE Barranco, L Visa, P Navarro Cells 9 (3), 689, 2020 | 26 | 2020 |
| Poly (ADP-ribose) polymerases: new players in the pathogenesis of exocrine pancreatic diseases N Martínez-Bosch, ME Fernández-Zapico, P Navarro, J Yélamos The American journal of pathology 186 (2), 234-241, 2016 | 24 | 2016 |
| Parp‐1 genetic ablation in Ela–myc mice unveils novel roles for Parp‐1 in pancreatic cancer N Martínez‐Bosch, M Iglesias, J Munné‐Collado, C Martínez‐Cáceres, ... The Journal of Pathology 234 (2), 214-227, 2014 | 22 | 2014 |
| Galectins in the tumor microenvironment: Focus on galectin-1 N Martínez-Bosch, P Navarro Tumor Microenvironment: Molecular Players–Part A, 17-38, 2020 | 18 | 2020 |
| Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard N Martínez-Bosch, P Navarro Oncoimmunology 3 (8), e952201, 2014 | 18 | 2014 |
| The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer N Martínez-Bosch, PE Guerrero, M Moreno, A José, M Iglesias, ... Oncotarget 7 (30), 48265, 2016 | 17 | 2016 |
| Electrochemical immunosensing of ST2: A checkpoint target in cancer diseases RM Torrente-Rodríguez, CMS Martín, M Gamella, M Pedrero, ... Biosensors 11 (6), 202, 2021 | 12 | 2021 |
| Electrochemical immunosensing of Growth arrest‐specific 6 in human plasma and tumor cell secretomes C Muñoz‐San Martín, V Pérez‐Ginés, RM Torrente‐Rodríguez, ... Electrochemical Science Advances 2 (4), e2100096, 2022 | 6 | 2022 |
| Glycans and galectins: sweet new approaches in pancreatic cancer diagnosis and treatment N Martínez-Bosch, P Navarro, S Srivastava Pancreatic cancer‑molecular mechanisms and targets. InTech, 305-28, 2012 | 5 | 2012 |
